Related Experiment Videos
Persistence of antigen-binding cells with surface tolerogen: isologous versus heterologous immunoglobulin carriers
Journal of Immunology (Baltimore, Md. : 1950)
|September 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Potential use of microwave technology in dermatology.
The Journal of dermatological treatment·2022
Finasteride for hair loss: a review.
The Journal of dermatological treatment·2021
Minoxidil: a comprehensive review.
The Journal of dermatological treatment·2021
Nondermatophyte mould onychomycosis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Preservation of MHC-Ia protective allele suppression of SIVmac239 in aged rhesus macaques.
Journal of immunology (Baltimore, Md. : 1950)·2026
Long-term Nlrp3 gain-of-function mutation promotes cardiac dysfunction independent of inflammasome in mice.
Journal of immunology (Baltimore, Md. : 1950)·2026
Differential requirements for cytokine signaling and local antigen in upper versus lower respiratory tract CD8+ TRM development.
Journal of immunology (Baltimore, Md. : 1950)·2026
CTLA4 rs3087243-A-linked haplotype is associated with increased CTLA-4 expression and suppressive function in human regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
TCRαβ repertoire plasticity defines universal CD8+ T cell responses directed at influenza-specific HLA-A*02:01-PB1413-421 epitope.
Journal of immunology (Baltimore, Md. : 1950)·2026
TNFα promotes brain-predominant EAE independent of IFNγ and IL-17A in HLA-DR3 transgenic mice.
Journal of immunology (Baltimore, Md. : 1950)·2026
Engineering immune cell engagers: From molecular constructs to biomaterial platforms.
Materials today. Bio·2026
Disseminated Tuberculosis With Ocular Involvement After 12 Years of Anti-TNF-α Therapy.
Case reports in ophthalmological medicine·2026
Off-Label Use of Monoclonal Antibodies in Developing Countries.
American journal of therapeutics·2026